lomustine has been researched along with Mast Cell Activation Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vincenti, S | 1 |
| Findji, F | 1 |
| Rassnick, KM | 1 |
| Bailey, DB | 1 |
| Russell, DS | 1 |
| Flory, AB | 1 |
| Kiselow, MA | 1 |
| Intile, JL | 1 |
| Malone, EK | 1 |
| Balkman, CE | 1 |
| Barnard, SM | 1 |
1 trial available for lomustine and Mast Cell Activation Disease
| Article | Year |
|---|---|
A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, | 2010 |
1 other study available for lomustine and Mast Cell Activation Disease
| Article | Year |
|---|---|
Influence of treatment on the outcome of dogs with incompletely excised grade-2 mast cell tumors.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dog Diseases; Dogs; Follow-Up Studies; Lo | 2017 |